Deutsche Bank AG Acquires Shares of 1,913 Elanco Animal Health (NASDAQ:ELAN)

Deutsche Bank AG acquired a new stake in Elanco Animal Health (NASDAQ:ELAN) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 1,913 shares of the company’s stock, valued at approximately $60,000.

A number of other hedge funds have also recently made changes to their positions in the business. American International Group Inc. purchased a new position in shares of Elanco Animal Health during the 4th quarter worth $48,000. Public Employees Retirement Association of Colorado purchased a new position in shares of Elanco Animal Health during the 4th quarter worth $83,000. Metropolitan Life Insurance Co. NY purchased a new position in shares of Elanco Animal Health during the 4th quarter worth $112,000. Neuburgh Advisers LLC purchased a new position in shares of Elanco Animal Health during the 4th quarter worth $127,000. Finally, NumerixS Investment Technologies Inc purchased a new position in shares of Elanco Animal Health during the 4th quarter worth $146,000.

Shares of Elanco Animal Health stock traded down $0.46 on Friday, reaching $33.80. 6,069,038 shares of the company were exchanged, compared to its average volume of 6,567,116. The stock’s 50 day moving average is $32.70. Elanco Animal Health has a 1-year low of $28.00 and a 1-year high of $37.61.

Elanco Animal Health (NASDAQ:ELAN) last announced its quarterly earnings results on Thursday, May 9th. The company reported $0.25 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.22 by $0.03. The business had revenue of $731.10 million during the quarter, compared to analyst estimates of $743.40 million. During the same period last year, the company earned $0.33 earnings per share. The business’s revenue for the quarter was down .7% compared to the same quarter last year.

In other news, Director John P. Bilbrey acquired 7,750 shares of Elanco Animal Health stock in a transaction on Monday, May 13th. The stock was bought at an average price of $32.39 per share, for a total transaction of $251,022.50. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Several research analysts have recently commented on ELAN shares. Zacks Investment Research upgraded Elanco Animal Health from a “hold” rating to a “buy” rating and set a $37.00 price target on the stock in a report on Wednesday, June 19th. Bank of America upgraded Elanco Animal Health from a “neutral” rating to a “buy” rating and set a $30.95 price target on the stock in a report on Monday, March 18th. Finally, Morgan Stanley assumed coverage on shares of Elanco Animal Health in a report on Wednesday, March 13th. They issued an “equal weight” rating and a $34.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and seven have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $33.56.

Elanco Animal Health Company Profile

There is no company description available for Elanco Animal Health Inc

Recommended Story: The mechanics of the bid-ask spread in trading

Institutional Ownership by Quarter for Elanco Animal Health (NASDAQ:ELAN)

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.